Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122596) titled 'EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Pakistan Navy Station Shifa Hospital
Condition:
Sepsis
Bacterial Infection
Intervention:
Drug: Meropenem Infusion
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: April 1, 2024
Target Sample Size: 150
Countries of Recruitment:
Pakistan
To know more, visit https://clinicaltrials.gov/ct2/show/NCT0...